Navigation Links
OTC Financial Network Issues Corporate Profile on ProtoKinetix Inc.
Date:10/28/2008

VANCOUVER, British Columbia, Oct. 28 /PRNewswire-FirstCall/ -- ProtoKinetix Inc. (OTC Bulletin Board: PKTX), a biotech company focused on the research, development and commercialization of patented anti-aging glycopeptides (AAGPs(TM)), announced today that OTC Financial Network (OTCFN), a division of National Financial Communications Corp. (NFC), has issued a corporate profile on the Company. The OTCFN Report includes details on the ProtoKinetix technology platform, its multiple commercial applications, global target markets and management team. Interested parties can download the report at http://www.otcfn.com/pktx/pktx-report.pdf.

"Dr. Castelot-Deliencourt, chief scientist for ProtoKinetix, has achieved what was previously thought to be the impossible. She created a synthetic version of AFGP (Anti-Freeze Glycoprotein), a naturally occurring compound that enables cell survival in freezing temperatures. Her lab-created version is the industry's first stable, non-toxic and bioactive compound, even at low concentrations. Patented and trademarked by ProtoKinetix as AAGPs(TM), this revolutionary technology and its derivatives have shown to increase cellular health, survival and seem to have anti-inflammatory properties," said Geoffrey Eiten, publisher of the OTCFN Report.

"This year, ProtoKinetix entered its exciting commercial development phase, establishing partnerships with skin care manufacturers, and umbilical cord blood and health care companies to research and develop life-enhancing applications of AAGP(TM). The Company's goal is to begin generating recurring licensing revenues and royalty fees in 2009, and to increase shareholder value over the long-term," concluded Eiten.

About ProtoKinetix

ProtoKinetix, Inc. is a biotechnology company that has developed and patented a family of synthetic anti-aging glycopeptides (AAGP(TM)) for medicine and the biotechnology and cosmetic industries. PKTX is currently in dialog with major corporations and institutions who have contacted the Company about the broad range of applications for AAGP(TM) products. For more information, visit http://www.protokinetix.com.

OTC Financial Network serves as special advisor to ProtoKinetix Inc. and has received fees for services, including two hundred and fifty-thousand shares of restricted stock, in addition to an option to purchase two-hundred fifty-thousand shares at an exercise price of twenty cents per share, for the creation and implementation of an awareness program, including the OTC FN Report. This is not an offer to buy or sell securities. Information or opinions in this release are presented solely for informative purposes, and are not intended nor should they be construed as investment advice. A full disclaimer can be found online by visiting http://www.otcfn.com/pktx/disclaimer.html.

The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Some information included in this press release contains statements that are forward-looking. Such forward-looking information involves significant risks and uncertainties that could affect anticipated results in the future and, accordingly, these results may differ materially from those expressed in any forward-looking statements made by or on behalf of the Company. For a description of additional risks and uncertainties, please refer to the Company's filings with the Securities and Exchange Commission.

CONTACT

At OTC Financial Network:

Rick McCaffrey, Investor Relations

781-444-6100 x625

rick@otcfn.com

http://www.otcfn.com/pktx

At ProtoKinetix:

Blair Henderson

604-687-9887

Email: info@protokinetix.com


'/>"/>
SOURCE ProtoKinetix Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
2. Avicena Group to Present at Noble Financial Conference
3. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
4. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
5. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
6. Avitar Reports Third Quarter Financial Results for Fiscal 2007
7. Response Genetics Reports Second Quarter 2007 Financial Results
8. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
9. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
10. GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update
11. CEL-SCI to Present at the Noble Financial Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... June 27, 2016  Sequenom, Inc. (NASDAQ: ... healthier lives through the development of innovative products and ... the United States denied its petition ... claims of Sequenom,s U.S. Patent No. 6,258,540 (",540 Patent") ... established by the Supreme Court,s Mayo Collaborative Services v. ...
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... ... 24, 2016 , ... Researchers at the Universita Politecnica delle Marche in Ancona ... or pleural mesothelioma. Their findings are the subject of a new article on the ... are signposts in the blood, lung fluid or tissue of mesothelioma patients that can ...
(Date:6/23/2016)... A person commits a crime, and the detective ... the criminal down. An outbreak of foodborne illness ... (FDA) uses DNA evidence to track down the bacteria that ... It,s not. The FDA has increasingly used a complex, cutting-edge ... illnesses. Put as simply as possible, whole genome sequencing is ...
Breaking Biology Technology:
(Date:6/22/2016)... , June 22, 2016   Acuant ... and verification solutions, has partnered with RightCrowd ... solutions for Visitor Management, Self-Service Kiosks and ... products that add functional enhancements to existing ... corporations and venues with an automated ID ...
(Date:6/16/2016)... 16, 2016 The global ... to reach USD 1.83 billion by 2024, according ... Inc. Technological proliferation and increasing demand in commercial ... to drive the market growth.      ... The development of advanced multimodal techniques for biometric ...
(Date:6/7/2016)...  Syngrafii Inc. and San Antonio Credit Union ... integrating Syngrafii,s patented LongPen™ eSignature "Wet" solution into ... result in greater convenience for SACU members and ... existing document workflow and compliance requirements. ... Highlights: ...
Breaking Biology News(10 mins):